First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.18 USD 0.88% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

PHAT Price Targets Summary
Phathom Pharmaceuticals Inc

Wall Street analysts forecast PHAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHAT is 23.17 USD with a low forecast of 10.1 USD and a high forecast of 29.4 USD.

PHAT Lowest Forecast
Wall Street Target
10.1 USD
10% Upside
PHAT Average Forecast
Wall Street Target
23.17 USD
152% Upside
PHAT Highest Forecast
Wall Street Target
29.4 USD
220% Upside
Lowest
Price Target
10.1 USD
10% Upside
Average
Price Target
23.17 USD
152% Upside
Highest
Price Target
29.4 USD
220% Upside

PHAT Last Price Targets
Phathom Pharmaceuticals Inc

The latest public price target was made on Jan 5, 2024 by Joseph Stringer from Needham , who expects PHAT stock to rise by 183% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Joseph Stringer
Needham
26 USD
Upside 183%
3 months ago
Jan 5, 2024
"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
Benzinga
Joseph Stringer
Needham
Price Target 26 USD
Upside/Downside 183%
View Source
Phathom Pharmaceuticals Inc Competitors:
Price Targets
SEQUENT
SeQuent Scientific Ltd
7% Upside
PBH
Prestige Consumer Healthcare Inc
9% Upside
C
CONCORDBIO
Concord Biotech Ltd
4% Downside
001630
Chongkundang Holdings Corp
4% Upside
SEQUENT
SeQuent Scientific Ltd
7% Upside
PBH
Prestige Consumer Healthcare Inc
9% Upside
C
CONCORDBIO
Concord Biotech Ltd
4% Downside
001630
Chongkundang Holdings Corp
4% Upside
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
480% Upside
A
000739
Apeloa Pharmaceutical Co Ltd
55% Upside
N
4516
Nippon Shinyaku Co Ltd
78% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
5% Downside

Revenue
Forecast

Revenue Estimate
Phathom Pharmaceuticals Inc

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 730%.

N/A
Past Growth
730%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

See Also

Summary
PHAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHAT stock valuation using valuation multiples.
Wall Street Estimates
PHAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHAT's stock price target?
Price Target
23.17 USD

According to Wall Street analysts, the average 1-year price target for PHAT is 23.17 USD with a low forecast of 10.1 USD and a high forecast of 29.4 USD.

What is Phathom Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
730%

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 730%.

ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.